title: Successful thrombolysis following enoxaparin therapy in two pediatric patients with congenital heart disease presenting with intracardiac and cerebral thrombosis.
abstract: Enoxaparin displays fibrinolytic activity through stimulation of endothelial release of tissue plasminogen activator. Moreover, enoxaparin increases the release of tissue factor pathway inhibitor, which inhibits coagulation activity. However, there are only few reports regarding the use of enoxaparin for the treatment of children with thrombosis complicating congenital heart disease. We report the clinical findings from two patients, one child with an A. cerebri media infarction and another with a left ventricular thrombus. In both cases successful thrombolysis was obtained by intravenous administration of enoxaparin. The first patient was a 12-year-old girl with an atrioventricular septal defect, who underwent biventricular repair at the age of 8 months. She presented with right-sided middle cerebral artery infarction. Thrombolysis was contraindicated, because she was beyond the therapeutic window recommended by accepted guidelines. Enoxaparin 2.5 mg/kg/d was administered as a continuous intravenous infusion (CII). The MRI 10 days later revealed a reopened middle cerebral artery and she experienced complete remission of the neurological signs. The second patient was a 16-year-old boy who had tetralogy of Fallot corrected in late infancy. He presented with severe heart failure and a mural thrombus in the left ventricular apex. Enoxaparin was administered and resulted in complete disappearance of the thrombus within a week. According to our experience, CII of enoxaparin was safe and well tolerated without secondary bleeding and resulted in complete dissolution of the thrombi without secondary embolization. Therefore, CII of enoxaparin may be a possible alternative for the treatment of thrombotic complications in children with contraindications against conventional thrombolytic therapy.
authors.affiliation: Department of Pediatric Cardiology, University Children's Hospital, Hoppe-Seyler-Strasse 1, 72076 Tuebingen, Germany.
authors.forename: Gesa
authors.initials: G
authors.lastname: Wiegand
authors.affiliation: Department of Pediatric Cardiology, University Children's Hospital, Hoppe-Seyler-Strasse 1, 72076 Tuebingen, Germany.
authors.forename: Vanya
authors.initials: V
authors.lastname: Icheva
authors.affiliation: Department of Pediatric Neurology, University Children's Hospital, Tuebingen, Germany.
authors.forename: Martin
authors.initials: M
authors.lastname: Schöning
authors.affiliation: Department of Pediatric Cardiology, University Children's Hospital, Hoppe-Seyler-Strasse 1, 72076 Tuebingen, Germany.
authors.forename: Michael
authors.initials: M
authors.lastname: Hofbeck
keywords: Children; Enoxaparin; Low-molecular-weight heparin; Thrombosis